Ascites During Selpercatinib Treatment: Need for a Multidisciplinary Approach
J Thorac Oncol
.
2023 Feb;18(2):e9-e10.
doi: 10.1016/j.jtho.2022.09.229.
Authors
Leonardo Provenzano
1
,
Silvia Damian
1
,
Matteo Duca
1
,
Serena Della Valle
2
,
Filippo Guglielmo Maria De Braud
3
Affiliations
1
Medical Oncology 1 Department, Fondazione IRCCS "Istituto Nazionale dei Tumori,", Milan, Italy.
2
Nutritional Department, Fondazione IRCCS "Istituto Nazionale dei Tumori,", Milan, Italy.
3
Medical Oncology 1 Department, Fondazione IRCCS "Istituto Nazionale dei Tumori,", Milan, Italy. Electronic address: filippo.debraud@istitutotumori.mi.it.
PMID:
36682848
DOI:
10.1016/j.jtho.2022.09.229
No abstract available
Publication types
Letter
Comment
MeSH terms
Ascites*
Humans
Lung Neoplasms* / drug therapy
Pyrazoles
Pyridines
Substances
selpercatinib
Pyrazoles
Pyridines